PureTech Health plc (LON:PRTC - Get Free Report) passed below its fifty day moving average during trading on Wednesday . The stock has a fifty day moving average of GBX 129.90 ($1.73) and traded as low as GBX 122.60 ($1.64). PureTech Health shares last traded at GBX 123 ($1.64), with a volume of 1,071,889 shares traded.
PureTech Health Stock Performance
The company has a debt-to-equity ratio of 45.82, a current ratio of 3.68 and a quick ratio of 2.51. The firm has a 50 day moving average of GBX 128.94 and a two-hundred day moving average of GBX 145.27. The stock has a market cap of £378.48 million, a PE ratio of -5.17 and a beta of 1.02.
About PureTech Health
(
Get Free Report)
PureTech Health plc, a clinical-stage biopharma company, focuses on developing medicines for diseases caused by dysfunctions in the nervous, gastrointestinal, and immune systems. The company is developing a microbiome immune system drug-discovery platform and drug candidates for immune-mediated diseases; and products to induce weight loss and enhance glycaemic control through an orally administered capsule.
Featured Articles
Before you consider PureTech Health, you'll want to hear this.
MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and PureTech Health wasn't on the list.
While PureTech Health currently has a Buy rating among analysts, top-rated analysts believe these five stocks are better buys.
View The Five Stocks Here
Enter your email address and we'll send you MarketBeat's list of ten stocks that are set to soar in Spring 2025, despite the threat of tariffs and other economic uncertainty. These ten stocks are incredibly resilient and are likely to thrive in any economic environment.
Get This Free Report
Like this article? Share it with a colleague.
Link copied to clipboard.
